Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
CareTech acquisition of Cambian given the all-clear

Specialist care provider CareTech’s acquisition of Cambian will now go ahead after the Competition and Markets Authority (CMA) gave the deal the all-clear.

Under the terms of the reverse merger, CareTech will pay £372 million for Cambian – leaving Cambian shareholders with around 36% of the enlarged company’s shares.

The deal will create Britain’s second biggest social care operator by revenue, controlling 4% a £16 billion UK market.

The CMA launched an investigation in October 2018 amid fears that the acquisition would threaten competition and lead to excessive market power.

Farouq Sheikh, Executive Chairman of CareTech, said: "We are delighted by the CMA's decision and would like to place on record our appreciation to all involved during the CMA process particularly the executive teams at CareTech and Cambian. We will now move forward with the integration, creating value for all our stakeholders through the highest quality service offerings and significant synergies."

Posted on: 08/02/2019

Latest news stories

21/02/2019
Cancer care provider Proton Partners International is expected to launch an initial public offering with an estimated valuation of £320 million on London’s NEX Exchange.
21/02/2019
Renaissance Care chairman Robert Kilgour has criticised the inaction of key public bodies to respond to unnecessary local authority spending on elderly care home.
20/02/2019
The European Medicines Agency has lost a court battle to break a London office lease, despite the UK’s exit from the EU and the agency’s subsequent relocation to Amsterdam.
20/02/2019
Minister for care Caroline Dinenage has defended delays to the social care Green Paper in a session in Parliament.
19/02/2019
UK healthcare REIT Primary Healthcare Properties is funding and acquiring a purpose-built primary care centre in Ireland.


Civica


HealthInvestor blog
Independent sector involvement in the NHS is challenging for those on both sides of the public/private divide

Click here to view the HealthInvestor blog


Chief executive and charity advocate torn between the left and the right hemisphere of the brain
In theory, 2018 was a sellers’ market. At a macro-level there was plenty of dry powder looking for investment and a finite number of quality assets to invest it in, and as a result, multiples edged upwards. While it was a hot market, some high-profile companies up for sale have yet to transact
The NHS is championing integrated care services to meet increasing health needs. Private providers should be playing an essential role – but do they risk being sidelined by the politics of privatisation? Marie Cahalane reports
Home care is a sector that Darryn Gibson, chief executive of Healthcare at Home, believes “has not been made enough of”. After 10 months in the job, and with big plans on the horizon, Marie Cahalane catches up with him
When it comes to health technology, the focus is often on fixing the symptoms of poor patient flow or scheduling, rather than addressing the root causes. However, a burgeoning market for operational technology may provide some welcome relief

Click here to search all feature articles



Company profile: Octopus Healthcare
Marie Cahalane speaks to Octopus Healthcare chief executive Benjamin Davis as he reflects on a prosperous 2018 and considers what the next year holds
Read more


Christie + Co

my images



NHS Partnerships

The 10 Year NHS Plan hints at scrapping competitive tendering for independent sector providers. Rob Munro reflects on recent health service reforms and considers what it all means for the health investor community
Read more